AOL Money & Finance

medi posts

Feed

Gilead rising on flu-prevention efforts

Gilead Sciences Inc. (NASDAQ: GILD) opened at $81.24. So far today the stock has hit a low of $80.48 and a high of $82.17. As of 10:45, GILD is trading at 81.85, up 1.21 (1.5%).

The stock made a strong push in early spring to reach the low 80's and a one year high of 84.47 in May. The US Government has recently been ramping up efforts to fight against any future potential flu pandemic, including awarding multi-million dollar contracts to Sanofi-Aventis (NYSE: SNY) and MedImmune (NASDAQ: MEDI) to increase their capacity to produce flu vaccines. GILD, maker of Tamiflu, could stand to benefit from such efforts as well. Recent technical indicators for GILD have been bullish but deteriorating, while S&P gives the stock a 4 STARS (out of 5) buy rating.

For a bullish hedged play on this stock, I would consider an August bull-put credit spread below the $70 range. GILD hasn't been below $70 since January and has shown support around $78 recently. This trade could be risky if the FDA finds trouble with one of GILD's drugs, but even if that happens, this position could be protected by the support around $70 combined with its 200 day moving average, which is currently at $71 and rising.

Brent Archer is an options analyst and writer at Investors Observer. Do you have any deadwood in your portfolio? Check out the 18 Warning Signs That Tell You When To Dump A Stock.

DISCLOSURE: Mr. Archer owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about. At publication time, Brent neither owns nor controls a position in GILD or MEDI. He does control a bullish hedged position in SNY.

Market highlights for next week: Markets closed Monday

Here is a quick look at this upcoming holiday shortened week.

Monday May 28
  • Markets closed for Memorial Day holiday.
  • PDUFA date for MedImmune Inc's (NASDAQ: MEDI) sBLA for CAIV-T.
Tuesday May 29
Wednesday May 30
Thursday May 31
Friday June 1

Analyst downgrades 4-27-07: CVX, JNPR, SIRI, SYMC and WEN downgraded today

MOST NOTEWORTHY: AstraZeneca plc (AZN), Aeroflex Inc (ARXX), Symantec Corp (SYMC), Chevron Corp (CVX) and Exxon Mobil Corp (XOM) were just some of today's noteworthy downgrades:
  • HSBC downgraded shares of AstraZeneca plc (NYSE: AZN) to Neutral from Overweight as the firm believes investors will have to wait until 2009 for the company to start benefiting from its strategy.
  • Aeroflexx Inc (NASDAQ: ARXX) was cut to Hold from Buy at Jefferies with a $14 target based on valuation.
  • Thomas Weisel downgraded shares of Symantec Corp (NASDAQ: SYMC) to Market Weight from Overweight citing a lack of near-term catalysts and increased risk from transitions in its business model.
  • Chevron Corp (NYSE: CVX) was removed from AG Edwards' Focus Portfolio. The firm believes Chevron offers less upside potential than other companies in the sector.
  • Exxon Mobil (NYSE: XOM) was downgraded to Hold from Buy on valuation and its balanced risk/reward profile...
OTHER DOWNGRADES:
  • Piper Jaffray cut Juniper Networks, Inc (NASDAQ: JNPR) to Market Perform from Outperform with a $20 target.
  • Hecla Mining Co (NYSE: HL) was cut to Sector Underperformer from Sector Performer at CIBC based on valuation.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Option update 4-23-07: MSFT option implied volatility flat into EPS

Daily Option Update is provided by Stock Options Specialist Paul Foster of theflyonthewall.com.

Bausch & Lomb
-(NYSE: BOL) volatility suggests slightly larger Risk on renewed chatter. BOL, is recently up $3.55 to $58.47, on renewed takeover chatter. BOL has a market cap of $3.15 billion with long term debt of $831 million. BOL has cash & short term investment of $731 million. BOL May option implied volatility of 30 is near its 26-week average of 28 according to Track Data, suggesting slightly larger price risks.

Microsoft-(NASDAQ: MSFT) implied volatility suggests non-directional Risk into 4/26 EPS. MSFT will report EPS on 4/26/07. McAdams Wright Ragen has a Buy rating with a $35 price target on MSFT. MCAD says: "We expect FY08 guidance to be in the range of existing estimates and expect no major surprises." MSFT option implied volatility of 22 is near its 26-week average according to Track Data, suggesting non-directional risk.

Option volume leaders today are: MedImmune Inc. (NASDAQ: MEDI), Dendreon Corp. (NASDAQ: DNDN) and Apple, Inc. (NASDAQ: AAPL).


Before the bell 4-23-07: Will markets make the push to 13,000?

Markets seem poised to open flat to a little higher as indicated by stock futures early on this Monday morning ahead of another week full of earnings reports and economic data releases. Several deals are also in the news today.

Last week, the Dow closed at a record high as on Friday investors weighed the possibility and implications of the Dow hitting 13,000. The S&P 500 and the Nasdaq hit six-year highs as well.

This week, despite the economic calendar being light today, investors will weigh several economic releases, including data on the housing market and GDP for the first quarter. Earnings season will continue in full force with Texas Instruments Inc. (NYSE: TXN) set to report after the close today. It is expected to report Q1 earnings per share of $0.31 according to Reuters Estimates.

Other earnings this week include six Dow companies: AT&T, Exxon Mobil, Microsoft, Boeing, DuPont and 3M. In addition, Apple, Ford and XM Satellite are scheduled.

Several deals will weigh on investors' mind today:
Overseas, Japanese stocks ended flat ahead of a busy earnings week, but most Asian markets closed higher. European stocks, however, are trading lower now, falling from a six-years high due to concern companies may spend too much on mergers and acquisitions following the Barclays and ABN merger.

Analyst downgrades 4-17-07: CKFR, JDSA, MEDI and S all downgraded today

MOST NOTEWORTHY: CheckFree Corp (CKFR), Sprint Nextel Corp (S) and the semiconductor capital equipment sector were some of today's more noteworthy downgrades:
OTHER DOWNGRADES:
  • ThinkEquity cut Jones Soda Co (NASDAQ: JSDA) to Source of Funds from Buy based on valuation.
  • Goldman is now cautious on the biofuel sector, downgrading the group to Cautious from Neutral.
  • William Blair downgraded shares of Medimmune, Inc (NASDAQ: MEDI) to Market Perform from Outperform.
  • Credit Suisse downgraded shares of Big 5 Sporting Goods Corp (NASDAQ: BGFV) to Underperform from Neutral citing valuation.
  • Wachovia dropped Inkeepers USA Trust (NYSE: KPA) to Underperform from Outperform based on the acquisition from Apollo Investment Corp (AINV). Citigroup cut Inkeepers to Hold from Buy.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst downgrades 4-13-07: JBHT, LMT, LTD and MEDI downgraded today

MOST NOTEWORTHY: Some of today's noteworthy downgrades were Medimmune Inc (MEDI), J.B. Hunt (JBHT), Lockheed Martin (LMT), Komag (KOMG) and Victor Corp (VICR):
  • Freidman Billings cut Medimmune inc (NASDAQ: MEDI) to Market Perform from Outperform on valuation. Prudential downgraded shares to Neutral from Overweight and recommended investors take profits in the company.
  • J.B. Hunt Transport Services Inc (NASDAQ: JBHT) was downgraded to Peer Perform from Outperform at Bear Stearns citing valuation.
  • Lockheed Martin (NYSE: LMT) was removed from Goldman Sachs Conviction Buy List and prefers L-3 Communication (LLL) over the large-cap aerospace/defense company.
  • Komag Inc (NASDAQ: KOMG) was downgraded to Sell from Neutral at American Technology as they believe industry fundamentals have weakened and that the Seagate (STX) preannouncement will increase pricing pressure.
OTHER DOWNGRADES:
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst downgrades 4-04-07: Cephalon, First Data & Dreamworks Animation downgraded today

MOST NOTEWORTHY: First Data Corp (FDC), Pinnacle Entertainment, Inc (PNK), Cephalon, Inc (CEPH) and Verint Systems Inc (VRNT) were some of today's downgrades:
  • UBS downgraded First Data Corp (NYSE: FDC) to Neutral from Buy following the acquisition by KKR.
  • Pinnacle Entertainment (NYSE: PNK) was cut to Hold from Buy at Matrix USA, as the firm believes post-hurricane reconstruction efforts are leading to significant capital expenditures, which limits upside.
  • Cephalon Inc (NASDAQ: CEPH) was removed from American Technology's Focus List with shares up 15% in three weeks as the approval of Nuvigil without a Black Box warning has passed.
  • JP Morgan cut shares of Verint Systems (NASDAQ: VRNT) to Underweight from Neutral, citing risks and costs associated from the Witness Systems' (WITS) acquisition.
OTHER DOWNGRADES:
  • Labor Ready, Inc (NYSE: LRW) was downgraded to Sell from Neutral at Goldman based on the slowdown in U.S. residential construction activity.
  • Friedman Billings cut CompuDyne Corp (NASDAQ: CDCY) to Market Perform from Outperform following Q4 results.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst downgrades 3-20-07: Medimmune Inc & Take-Two Interactive Software downgraded today

MOST NOTEWORTHY: MedImmune, Inc (MEDI), Take-Two Interactive Software (TTWO) and Tractor Supply Co (TSCO) were some of today's more notable downgrades:
  • Bear Stearns downgraded MedImmune Inc (NASDAQ: MEDI) to Peer Perform from Outperform based on limited upside over the next 6-12 months.
  • Take-Two Interactive Software (Nasdaq: TTWO) was cut by Kaufman to Sell from Hold with a $17 target. Kaufman believes Take-Two is overvalued based on fundamentals.
  • Tractor Supply (NASDAQ: TSCO) was downgraded by Matrix to Sell from Hold. The firm expects high livestock feed and fertilizer prices to cut demand for Tractor Supply's target customer base.
OTHER DOWNGRADES:
  • Martin Midstream Partners LP (NASDAQ: MMLP) was downgraded to Sector Perform from Outperform based on valuation.
  • Friedman Billings cut Opteum Inc (NYSE: OPX) to Underperform from Market Perform citing the mounting losses in sub-prime mortgage loans and notes that servicing rights are also under pressure.
  • JP Morgan downgraded OMI Corp (NYSE: OMM) to Neutral from Overweight.
  • Kaufman downgraded First Charter Corp (NASDAQ: FCTR) to Market Perform from Outperform, citing the macro environment for the downgrade.
  • CIBC downgraded Saifun Semiconductors Ltd (NASDAQ: SFUN) to Sector Performer from Outperform after checks in Asia indicated that Hynix is no longer considering NROM as they believe SFUN's licensing momentum is diminishing.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Market highlights for next week: Playboy, Garmin, Biogen reporting

Monday February 12
  • Broadcom Corporation (NASDAQ: BRCM) to hold a 10:30am press conference from Barcelona on 3GSM.
  • US and South Korea to hold Free-Trade Agreement talks from 2/11 to 2/14.
Tuesday February 13
  • Extreme entertainment earnings:
    • World Wrestling Entertainment (NYSE: WWE), conference call at 11am.
    • Playboy Enterprises (NYSE: PLA), conference call at 11am. Note that Playboy was recently downgraded by RBC Capital Markets and Sanders Morris Harris. Sanders Morris said the company will either issue guidance below consensus expectations or none at all on the call.
  • PDUFA date for Pfizer, Inc's (NYSE: PFE) Fesoterodine, a new drug candidate for the treatment of an overactive bladder.
Wednesday February 14
  • Garmin Limited (NASDAQ: GRMN) to report Q4 earnings, conference call at 11am.
  • MGM Mirage (NYSE: MGM) to report Q4 earnings, conference call at 11am.
  • PDUFA date for Acambis plc's (OTC: ACAMY) ACAM-2000, a smallpox vaccine derived from Dryvax, a first-generation vaccine used during the global eradication program.
  • PDUFA date for MedImmune Inc's (NASDAQ: MEDI) CAIV-T, an investigational intranasal, cold-adapted trivalent influenza vaccine.
Thursday February 15
  • Biogen Idec Inc (NASDAQ: BIIB) to report Q4 earnings, conference call at 8:30am. On February 2, JP Morgan recommended buying Biogen before its quarterly report, saying the Tysbari uptake should be better than current expectations.
Friday February 16
  • Jack in the Box Inc (NYSE: JBX) to hold annual shareholder meeting at 3pm.

Analyst downgrades 2-06-07: Wendy's shares too rich, downgrade to Sell

MOST NOTEWORTHY: Wendy's International Inc (WEN) and NOVA Chemicals Corp (NCX) were today's most notable downgrades:
  • Matrix USA downgraded shares of fast-food restaurant Wendy's International Inc (NYSE: WEN) to Sell from Hold to reflect the company's slowing revenues, increasing expenses and valuation.
  • CIBC downgraded NOVA Chemicals Corp (NYSE: NCX) to Sector Underperformer from Sector Performer, lowering their target to $27.50 from $31 as they believe margins will be squeezed in 2008 once Middle Eastern supply begins to impact export markets.

OTHER DOWNGRADES:
  • Following the company's lower guidance, UBS downgraded National Semiconductor Corp (NYSE: NSM) to Neutral from Buy with a $25 target, while Citigroup downgraded National Semi to Hold from Buy with a $27 target.
  • Recent strength in Royal Caribbean Cruises Ltd (NYSE: RCL) forced Bank of America to remove it from their Top Pick list.
  • Jefferies downgraded shares of Triad Hospitals Inc (NYSE: TRI) to Hold from Buy pending the buyout.
  • JP Morgan downgraded shares of Altiris Inc (NASDAQ: ATRS) to Neutral from Outperform based on the Symantec (SYMC) acquisition.
  • Thomas Weisel downgraded Medimmune Inc (NASDAQ: MEDI) to Market Perform from Outperform on valuation.
  • Matrix USA downgraded Secure Computing Corp (NASDAQ: SCUR) to Sell from Buy on valuation.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst upgrades 11-7-06: Swift gets a triple upgrade

MOST NOTEWORTHY: Swift Transportation (SWFT), JetBlue (JBLU) and Southwest (LUV) top today's list of upgrades.

  • Following Director Moyer's offer to buy Swift Transportation, Inc. (NASDAQ:SWFT) for $29 a share, the company was upgraded to Market Perform from Underperform at Wachovia, to Peer Perform from Underperform at Bear Stearns and to Neutral from Sell at Bank of America.
  • JetBlue Airways Corp. (NASDAQ:JBLU) was upgraded by Raymond James to Outperform from Market Perform following the October traffic report.
  • Southwest Airlines Co. (NYSE:LUV) was upgraded to Outperform from Underperform at Credit Suisse based on valuation.

OTHER UPGRADES:

  • Medimmune, Inc. (NASDAQ:MEDI) was upgraded to Outperform from Market Perform at Friedman, Billings Ramsey, citing Numax data and increased sales expectations for the drug.
  • Finally, H&R Block, Inc. (NYSE:HRB) was upgraded to Buy from Sell at Soleil. The firm believes H&R Block's decision to explore strategic alternatives could lead to a possible sale of the whole company or certain parts of the company.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA-4.9910,221.95
NASDAQ-7.822,146.24
S&P 500-3.061,090.02

Last updated: November 10, 2009: 12:14 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance